Full Stack Scale Leverage Conagen's end-to-end bioproduction model to collaborate on fermentation-based natural products, from proprietary strain development to world-scale production. The ability to scale from small lab batches to large-scale manufacturing while maintaining strict quality control supports rapid product-to-market timelines for customers in food, nutrition, flavor and fragrance, pharmaceutical, and renewable materials.

Biopolymer Partnerships Conagen's collaboration with Sumitomo Chemical on bio-based hydroxystyrene and poly p-hydroxystyrene demonstrates openness to joint development with chemical and materials players, opening opportunities to co-create bio-based monomers and polymers for plastics, coatings, and specialty materials.

Fermentation Proteins Proprietary fermentation-produced lactoferrin and other enzymes offer sustainable, nature-identical ingredients for dairy, infant nutrition, and functional foods, creating sales opportunities with ingredient suppliers and brands seeking bio-based proteins and enzymes.

Renewable Materials Conagen's work on biosynthetic polymers and monomers such as HS and PHS positions it to supply bio-based materials to plastics and coatings manufacturers, with opportunities for licensing, joint ventures, or contract manufacturing of renewable polymers.

Regional Advantage Based in the Boston biotech corridor, Conagen benefits from proximity to pharma, nutraceutical, and academic partners, enabling local development engagements, faster collaboration, and shorter supply chains for U.S. customers.